| Entry |
|
|---|
| Name |
Volanesorsen sodium (USAN);
Waylivra (TN) |
|---|
| Formula |
C230H320N63O125P19S19. 19Na
|
|---|
| Exact mass |
7596.8384
|
|---|
| Mol weight |
7601.891
|
|---|
| Remark |
|
|---|
| Efficacy |
Antihyperlipidemic, Apolipoprotein C3 inhibitor |
|---|
| Comment |
Antisense oligonucleotide
Treatment of familial chylomicronemia syndrome
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Organismal systems
Digestive system
APOC3
D11650 Volanesorsen sodium (USAN)
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11650
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11650
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
